NRF Annual Report 2018
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
PART B: PERFORMANCE<br />
Enhance strategic international engagements<br />
iThemba LABS concluded and maintained the following<br />
strategic international collaborations:<br />
• A collaboration with Integrating Activity (IA), the<br />
European Nuclear Science and Applications Research<br />
2 (ENSAR2), with financial support from the European<br />
Commission through the Horizon 2020 framework<br />
programme, which provided access to African<br />
researchers and students and access to iThemba LABS<br />
for European physicists;<br />
• A collaboration of iThemba LABS, Stellenbosch<br />
University, University of Oslo and University of California,<br />
Berkeley, received a grant of R7,5m over three years<br />
from the International Partnerships for Excellent<br />
Education and Research through the Norwegian<br />
Research Council. The participating universities will<br />
evaluate each other’s courses to determine a list of<br />
pre-approved undergraduate courses that will be a<br />
component of a ‘semester abroad’ pilot project;<br />
• An agreement was reached with the National Institute<br />
for Nuclear Science and Technology in Saclay, France,<br />
for support for the establishment of the South African<br />
Institute of Nuclear Technology and Science;<br />
• An MoU has been signed between iThemba LABS<br />
and Botswana International University of Science and<br />
Technology (BIUST). A pilot study to extend the shelf<br />
life of high-value perishable products by gamma/<br />
electron beam irradiation, was initiated by the iThemba<br />
LABS-BIUST collaboration. The primary objective is to<br />
investigate the dose-effect relationship for meat products<br />
exposed under different temperature conditions; and<br />
• JINR was funded by the DST to conduct a study with<br />
iThemba LABS on the effects of low doses of proton<br />
and neutron irradiations on neurotransmitters of the<br />
central nervous system to understand late normal tissue<br />
responses following particle therapy. Ethical approval<br />
for this study has been obtained from the Medical<br />
Research Council and specialised irradiation jigs are<br />
being prepared.<br />
BRACCO, a major stakeholder in the isotope Sr-82<br />
business in the USA, has signed an MOU and NDA for<br />
the future supply of Sr-82 by iThemba LABS. This will<br />
strengthen the facility’s market share and enhance the<br />
business case for the acquisition of a 70MeV cyclotron.<br />
<strong>NRF</strong> <strong>Annual</strong> <strong>Report</strong> 2017/18 95